70 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
to achieve high levels of subject retention and protocol compliance in endemic regions. The vaccine is approved in multiple endemic and non-endemic countries
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
Standards for the Professional Practice of Internal Auditing (IIA Standards)” issued by the Institute of Internal Auditors. (ii) System for retention
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
-generation dengue vaccine, and it considered the
- 15 -
Translation for reference purpose only
need to achieve high levels of subject retention
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
, and it considered the need to achieve high levels of subject retention and protocol compliance in endemic regions. The vaccine is approved in multiple endemic
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of Internal Auditing (IIA Standards)” issued by the Institute of Internal Auditors. (ii) System for retention and management of information concerning
6-K
EX-99.1
ancyuz
23 Jun 23
Current report (foreign)
6:13am
6-K
enpczp2qmec ilxs34k
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
8dvi3 dqs5dya
30 May 23
Current report (foreign)
6:11am
6-K
qwhbae806
11 Jul 22
Current report (foreign)
6:05am
6-K
c2px3kv5
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
r1i93 43juf7h6ayg8al
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
rlsu5u0e 01xexm
31 May 22
Current report (foreign)
12:00am
6-K
i1t89j5q1f 3hv
1 Nov 21
Current report (foreign)
6:04am
6-K
9cydj40c
6 Aug 21
Current report (foreign)
6:10am
6-K
cetrhv ix
19 Jul 21
Current report (foreign)
6:02am